ICU admission rates in Istanbul following the addition of favipiravir to the national COVID-19 treatment protocol.

COVID-19 favipiravir intensive care unit

Journal

Northern clinics of Istanbul
ISSN: 2536-4553
Titre abrégé: North Clin Istanb
Pays: Turkey
ID NLM: 101684520

Informations de publication

Date de publication:
2021
Historique:
received: 10 11 2020
accepted: 01 02 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 15 4 2021
Statut: epublish

Résumé

The objective of this study was to understand the observational relationship between adoption of favipiravir into the national COVID-19 treatment protocol and intensive care unit (ICU) admission rates in Istanbul due to COVID-19. Data were harvested from the "Public Health Management System-HSYS," which collate centrally the records of all known cases of COVID-19. The total number of cases, numbers admitted to ICU, and number undergoing intubation were compared between 2 time periods: 11 The percentage of patients requiring ICU admission diminished from 24% to 12%, whilst the percentage intubated fell from 77% to 66%. These differences were both statistically significant. The addition of favipiravir to the national COVID-19 treatment protocol may explain this rapid decrease in the rate of ICU admissions and intubation.

Identifiants

pubmed: 33851074
doi: 10.14744/nci.2021.60420
pii: NCI-8-119
pmc: PMC8039109
doi:

Types de publication

Journal Article

Langues

eng

Pagination

119-123

Informations de copyright

Copyright: © 2021 by Istanbul Northern Anatolian Association of Public Hospitals.

Déclaration de conflit d'intérêts

Conflict of Interest: No conflict of interest was declared by the authors.

Références

Drug Discov Ther. 2020;14(1):58-60
pubmed: 32147628
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Engineering (Beijing). 2020 Oct;6(10):1192-1198
pubmed: 32346491
J Chin Med Assoc. 2020 Jun;83(6):534-536
pubmed: 32243270
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449-463
pubmed: 28769016

Auteurs

Abdullah Emre Guner (AE)

Istanbul Health Directorate, Public Health Services, Istanbul, Turkey.

Aral Surmeli (A)

Medical Rescue Association of Turkey, Istanbul, Turkey.

Kemal Kural (K)

Istanbul Health Directorate, Monitoring, Evaluation and Statistics, Istanbul, Turkey.

Habip Yilmaz (H)

Istanbul Health Directorate, Department of Public Hospital Services, Istanbul, Turkey.

Erdogan Kocayigit (E)

Istanbul Health Directorate, Public Health Services, Istanbul, Turkey.

Esra Sahin (E)

Istanbul Health Directorate, Public Health Services, Istanbul, Turkey.

Perihan Alkan (P)

Istanbul Health Directorate, Infectious Diseases, Istanbul, Turkey.

Cemal Kazezoglu (C)

Health Sciences University, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.

Serdal Zelyurt (S)

Istanbul Health Directorate, Support Services, Istanbul, Turkey.

Kemal Memisoglu (K)

Istanbul Health Directorate, Director of Health, Istanbul, Turkey.

Isil Maral (I)

Department of Public Health, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.

Classifications MeSH